Jason A. Amello
2012 - ZIOPHARM Oncology
In 2012, Jason A. Amello earned a total compensation of $1.5M as Executive Vice President, Chief Financial Officer and Treasurer at ZIOPHARM Oncology.
Compensation breakdown
| Bonus | $61,250 |
|---|---|
| Option Awards | $1,071,480 |
| Salary | $226,827 |
| Stock Awards | $112,500 |
| Other | $195 |
| Total | $1,472,252 |
Amello received $1.1M in option awards, accounting for 73% of the total pay in 2012.
Amello also received $61.3K in bonus, $226.8K in salary, $112.5K in stock awards and $195 in other compensation.
Rankings
In 2012, Jason A. Amello's compensation ranked 4,631st out of 11,487 executives tracked by ExecPay. In other words, Amello earned more than 59.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,631 out of 11,487 | 60th |
Division Manufacturing | 1,615 out of 4,253 | 62nd |
Major group Chemicals And Allied Products | 369 out of 1,198 | 69th |
Industry group Drugs | 231 out of 920 | 75th |
Industry Pharmaceutical Preparations | 179 out of 700 | 74th |
Source: SEC filing on April 30, 2014.
Amello's colleagues
We found four more compensation records of executives who worked with Jason A. Amello at ZIOPHARM Oncology in 2012.